XEPRILA

Sanofi-aventis

Application Filed: 2000-05-30

Trademark Application Details

Mark For: XEPRILA® trademark registration is intended to cover the categories of pharmaceutical preparations, namely for preventing or treating central nervous system disturbances. [all]

Status

2022-10-16 UTC

DEAD REGISTRATION Cancelled Invalidated

The trademark application was registered, but subsequently it was cancelled or invalidated and removed from the registry.

Research	OneLook Acronym Finder
Serial Number	76059023
Registration Number	2796500
Mark Literal Elements	XEPRILA
Mark Drawing Type	1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S)
Mark Type	TRADEMARK
Standard Character Claim	No
Register	PRINCIPAL
Current Location	FILE REPOSITORY (FRANCONIA) 2004-01-05
Basis	44(e)
Class Status	SECTION 8 - CANCEL
Primary US Classes	006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	No
Intent To Use	No
Filed ITU	Yes
44D Filed	No
44E Current	Yes
66A Current	No
Current Basis	No
No Basis	No
Cancellation Code	2
Domestic Representative	Trademark & Patent Counselors of America, P.C.
Attorney Name	Mark I. Peroff
Attorney Docket Number	110.118
Law Office Assigned	L50
Employee Name	BROWN, BRIAN D

Timeline

2000-05-30	Application Filed
2001-04-17	Published
2001-04-17	Published for Opposition
2003-12-23	Trademark Registered
2004-01-05	Location: FILE REPOSITORY (FRANCONIA)
2010-07-31	Cancelled
2010-07-31	Status: Dead/Cancelled
2010-07-31	Status: Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this
2018-07-08	Transaction Date

Trademark Parties (Applicants & Owners)

Party:	SANOFI-AVENTIS
Address	174 AVENUE DE FRANCE 75013 PARIS FRANCE
Legal Entity Type	Corporation
Legal Entity State	FRANCE

Documents

Application	IMAGE/TIFF	2000-05-30
Drawing	IMAGE/TIFF	2000-05-30
Duplicate Application		2000-05-30
Duplicate Drawing		2000-05-30
XSearch Search Summary		2000-10-23
XSearch Search Summary		2000-10-23
Unclassified-Other		2001-02-21
Notice of Publication		2001-04-04
Notice of Allowance		2001-07-10
Extension of Time to File SOU		2002-01-04
Extension of Time to File SOU		2002-04-16
Paper Correspondence Incoming		2002-04-16
Extension of Time to File SOU		2002-12-18
Extension of Time to File SOU		2002-12-18
Paper Correspondence Incoming		2003-03-08
Paper Correspondence Incoming		2003-03-08
Paper Correspondence Incoming		2003-03-10
Extension of Time to File SOU	APPLICATION/XML,IMAGE/TIFF	2003-07-10
Extension of Time to File SOU		2003-07-11
Paper Correspondence Incoming		2003-08-05
File Jacket		2003-08-20
Unclassified-Other		2003-08-20
Registration Certificate		2003-12-23
Change of Address	APPLICATION/XML	2006-11-09

Attorney of Record

Mark I. Peroff
Kirkpatrick & Lockhart Nicholson Graham
599 Lexington Avenue
New York NY 10022-6030

Good, Services, and Codes

(CANCELLED)
IC 005. US 006 018 044 046 051 052. G & S: PHARMACEUTICAL PREPARATIONS, NAMELY FOR PREVENTING OR TREATING CENTRAL NERVOUS SYSTEM DISTURBANCES

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	PHARMACEUTICAL PREPARATIONS, NAMELY FOR PREVENTING OR TREATING CENTRAL NERVOUS SYSTEM DISTURBANCES

Trademark Filing History

Description	Date	Proceeding Number
CANCELLED SEC. 8 (6-YR)	2010-07-31
TEAS CHANGE OF CORRESPONDENCE RECEIVED	2006-11-09
REGISTERED-PRINCIPAL REGISTER	2003-12-23
Sec. 1(B) CLAIM DELETED	2003-11-06	61813
ASSIGNED TO EXAMINER	2003-08-27	76835
CASE FILE IN TICRS	2003-08-22
PETITION TO DIRECTOR - GRANTED	2003-08-14
PAPER RECEIVED	2003-08-05
TEAS EXTENSION RECEIVED	2003-07-10
NOTICE OF ALLOWANCE CANCELLED	2003-07-10
PETITION TO DIRECTOR RECEIVED	2003-03-08
PAPER RECEIVED	2003-03-08
SOU EXTENSION 3 GRANTED	2003-02-12
TEAS EXTENSION RECEIVED	2002-12-18
SOU EXTENSION 3 FILED	2002-12-18
SOU EXTENSION 2 GRANTED	2002-05-06
SOU EXTENSION 2 FILED	2002-04-16
PAPER RECEIVED	2002-04-16
SOU EXTENSION 1 GRANTED	2002-01-25
SOU EXTENSION 1 FILED	2002-01-04
NOA MAILED - SOU REQUIRED FROM APPLICANT	2001-07-10
PUBLISHED FOR OPPOSITION	2001-04-17
NOTICE OF PUBLICATION	2001-04-04
ASSIGNED TO EXAMINER	2000-10-23	72519
APPROVED FOR PUB - PRINCIPAL REGISTER	2000-10-23

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
XEPRILA 77500476 3776729 Dead/Cancelled	sanofi-aventis 2008-06-17
XEPRILA 76059023 2796500 Dead/Cancelled	SANOFI-AVENTIS 2000-05-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.